LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 139 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 6.44 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,644 | -38.8% | 125,362 | +28.5% | 0.00% | – |
| Q2 2023 | $223,419 | -33.7% | 97,563 | -29.7% | 0.00% | – |
| Q1 2023 | $337,104 | +10.4% | 138,726 | -13.2% | 0.00% | – |
| Q4 2022 | $305,253 | +35.7% | 159,818 | +70.6% | 0.00% | – |
| Q3 2022 | $225,000 | -43.0% | 93,686 | -55.8% | 0.00% | – |
| Q2 2022 | $395,000 | -10.8% | 212,153 | +0.0% | 0.00% | – |
| Q1 2022 | $443,000 | +17.2% | 212,066 | +120.9% | 0.00% | – |
| Q4 2021 | $378,000 | +1889.5% | 96,000 | +2315.7% | 0.00% | – |
| Q3 2021 | $19,000 | +111.1% | 3,974 | +99.6% | 0.00% | – |
| Q2 2021 | $9,000 | -88.8% | 1,991 | -85.4% | 0.00% | – |
| Q1 2021 | $80,000 | +73.9% | 13,648 | +0.0% | 0.00% | – |
| Q4 2020 | $46,000 | +1050.0% | 13,647 | +367.2% | 0.00% | – |
| Q3 2020 | $4,000 | -92.6% | 2,921 | -89.1% | 0.00% | – |
| Q2 2020 | $54,000 | +68.8% | 26,891 | +63.2% | 0.00% | – |
| Q1 2020 | $32,000 | -84.1% | 16,475 | -66.0% | 0.00% | – |
| Q4 2019 | $201,000 | +175.3% | 48,448 | +101.2% | 0.00% | – |
| Q3 2019 | $73,000 | +52.1% | 24,078 | +216.2% | 0.00% | – |
| Q2 2019 | $48,000 | +65.5% | 7,615 | +45.7% | 0.00% | – |
| Q1 2019 | $29,000 | -97.5% | 5,225 | -97.1% | 0.00% | -100.0% |
| Q4 2018 | $1,181,000 | -32.1% | 177,886 | +9.1% | 0.00% | 0.0% |
| Q3 2018 | $1,740,000 | +18.2% | 163,064 | +32.9% | 0.00% | 0.0% |
| Q2 2018 | $1,472,000 | -21.5% | 122,659 | -44.0% | 0.00% | 0.0% |
| Q1 2018 | $1,876,000 | +68.7% | 218,923 | +94.5% | 0.00% | – |
| Q4 2017 | $1,112,000 | -43.0% | 112,531 | -29.1% | 0.00% | -100.0% |
| Q3 2017 | $1,950,000 | -11.1% | 158,646 | +19.0% | 0.00% | 0.0% |
| Q2 2017 | $2,193,000 | +16.9% | 133,316 | +1.9% | 0.00% | 0.0% |
| Q1 2017 | $1,876,000 | +13.4% | 130,870 | +9.3% | 0.00% | 0.0% |
| Q4 2016 | $1,655,000 | +163.1% | 119,687 | +244.0% | 0.00% | – |
| Q3 2016 | $629,000 | -21.6% | 34,795 | -37.8% | 0.00% | -100.0% |
| Q2 2016 | $802,000 | +28.3% | 55,946 | +7.0% | 0.00% | – |
| Q1 2016 | $625,000 | -67.3% | 52,289 | -63.6% | 0.00% | -100.0% |
| Q4 2015 | $1,912,000 | +713.6% | 143,612 | +554.7% | 0.00% | – |
| Q3 2015 | $235,000 | +88.0% | 21,935 | +42.1% | 0.00% | – |
| Q2 2015 | $125,000 | – | 15,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |